Migraines are a common medical disorder characterized by recurrent headaches that are moderate to severe. Migraines are common among youth and adults, affecting 12% of people aged above 12. They affect day to day activities impairing the strength and vitality of people.
According to a research presented today at the Society of Interventional Radiology's 2017 Annual Scientific Meeting, scientists developed a method that involves minimally invasive treatment. The invasive treatment is effectively used for adults for the treatment of the migraine. A modified and innovative treatment is developed for children that is safe and effective and takes only minutes to get relief.
Also read: Researchers find that high-intensity exercises can reduce the risk of Type 2 diabetes and cardiovascular diseases
The method of treatment:
The innovative treatment called sphenopalatine ganglion (SPG) block does not utilize needle. A small flexible catheter is inserted into the each nostril into which local anesthetic is administered to the Sphenopalatine ganglion (SPG). SPG is a nerve bundle associated with the migraine and present at the back of the nose.
This treatment act on SPG by disabling it and resetting the headache circuit that breaks the cycle of migraines. The minimally invasive SPG block methods relieve the migraine instantly and the relief lasts for almost 3 months.
This novel treatment makes other medicated treatments redundant as they are prone to many severe side effects. If needed, the treatment can be repeated if or when the migraine returns.
No comments:
Post a Comment